Buprenorphine and Naloxone (Lannett Company, Inc..)
Welcome to the PulseAid listing for the Buprenorphine and Naloxone drug offered from Lannett Company, Inc… This Partial Opioid Agonist [EPC],Partial Opioid Agonists [MoA],Opioid Antagonist [EPC],Opioid Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Lannett Company, Inc.. |
| NON-PROPRIETARY NAME: | Buprenorphine and Naloxone |
| SUBSTANCE NAME: | BUPRENORPHINE; NALOXONE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Partial Opioid Agonist [EPC],Partial Opioid Agonists [MoA],Opioid Antagonist [EPC],Opioid Antagonists [MoA] |
| ROUTE: | SUBLINGUAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-09-19 |
| END MARKETING DATE: | 0000-00-00 |
Buprenorphine and Naloxone HUMAN PRESCRIPTION DRUG Details:
| Item Description | Buprenorphine and Naloxone from Lannett Company, Inc.. |
| LABELER NAME: | Lannett Company, Inc.. |
| DEA SCHEDULE: | CIII
|
| ACTIVE STRENGTH: | 2; .5(mg/1; mg/1) |
| START MARKETING DATE: | 2016-09-19 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 62175-452_3338cf77-39b1-4f04-8e65-f5067e3fccc4 |
| PRODUCT NDC: | 62175-452 |
| APPLICATION NUMBER: | ANDA205022 |
Other BUPRENORPHINE; NALOXONE Pharmaceutical Manufacturers / Labelers:
